Core Viewpoint - The company, Aipu Flavor Group Co., Ltd., has signed a Letter of Intent for Equity Acquisition with NovoSana (Europe) B.V. to acquire 100% equity of NovoSana (Taicang) Biotechnology Co., Ltd., with an estimated value of no less than RMB 450 million [3][11]. Group 1: Basic Information of the Agreement - The agreement aims to enhance the company's strategic layout and promote the extension of the industrial chain for high-quality development [5]. - The initial transaction involves the acquisition of 80% equity, with a second transaction planned after the performance commitment period [10][11]. - The estimated value of the target company's 100% equity is set at no less than RMB 450 million, with the final price to be determined through due diligence and negotiation [3][11]. Group 2: Financial and Operational Details - The target company, NovoSana (Taicang) Biotechnology Co., Ltd., specializes in the research, production, and sales of Omega-3 raw materials, including fish oil and algae oil [7]. - The target company has accumulated significant industry resources and has a client base that includes globally recognized health products and functional food companies [7]. - The financial status of the target company includes an estimated audited net profit of RMB 38 million for 2025 and total equity of RMB 148.64 million [12]. Group 3: Transaction Conditions and Obligations - The agreement stipulates that the buyer will pay a deposit of RMB 10 million within five working days after signing the Letter of Intent [15]. - The funding for the acquisition will come from the company's own or self-raised funds, ensuring no impact on normal operations [22]. - The agreement includes exclusivity clauses preventing the seller from engaging with third parties regarding the sale of the target company's equity until the transaction is completed [17].

Core Viewpoint - Aipu Co., Ltd. (603020.SH) has signed an equity acquisition intention agreement with Noah Sanno Europe to acquire 100% equity of Noah Sanno (Taicang) Biotechnology Co., Ltd. to enhance its strategic layout and achieve high-quality development [1] Group 1: Acquisition Details - The acquisition will occur in two phases: Aipu will first acquire 80% of the target company, followed by the remaining equity after the performance commitment period [1] - The transaction price will be determined based on due diligence, auditing, and valuation results, subject to negotiation between both parties [1] Group 2: Target Company Overview - The target company, established in 2009 and located in Taicang, Jiangsu, specializes in the research, production, and sales of Omega-3 raw materials, including fish oil and algae oil [1] - Its main products include refined fish oil and concentrated fish oil, and it has built a strong customer base comprising globally recognized health supplement, functional food and beverage, infant nutrition, and pet food clients [1]

Core Viewpoint - Aipu Co., Ltd. (603020.SH) has signed an equity acquisition intention agreement with Noah Sanno Europe to acquire 100% equity of Noah Sanno (Taicang) Biotechnology Co., Ltd. to enhance its strategic layout and achieve high-quality development [1] Group 1: Acquisition Details - The acquisition will occur in two phases: Aipu will first acquire 80% of the target company, followed by the remaining equity after the performance commitment period [1] - The final transaction price will be determined based on due diligence, auditing, and evaluation results, subject to negotiation between both parties [1] Group 2: Target Company Overview - The target company, established in 2009 and located in Taicang, Jiangsu, specializes in the research, production, and sales of Omega-3 raw materials, including fish oil and algae oil [1] - Its main products include refined fish oil and concentrated fish oil, and it has built a strong customer base comprising globally recognized health supplement, functional food and beverage, infant nutrition, and pet food clients [1]

Core Viewpoint - Aipu Spice Group Co., Ltd. plans to acquire 100% equity of NovoSana (Taicang) Biotechnology Co., Ltd. for a total valuation of no less than RMB 450 million, with the transaction structured in two phases [1][2]. Group 1: Acquisition Details - The first phase involves Aipu acquiring 80% of the equity for RMB 360 million, while the second phase will occur after the performance commitment period, acquiring the remaining 20% [1]. - The performance commitment period for the target company is set from 2026 to 2028, with a total net profit of no less than RMB 150 million expected during this period [1]. Group 2: Target Company Overview - NovoSana was established in 2007 with a registered capital of USD 5.1 million and is located in the Jiangsu Taicang Economic Development Zone [1]. - The company specializes in the development, production, and sales of food and food additives, particularly focusing on Omega-3 raw materials such as refined fish oil and concentrated fish oil [1]. - NovoSana's clients include globally recognized companies in health supplements, functional food and beverages, infant nutrition, and pet food sectors [1]. Group 3: Financial Projections - For the year 2024, NovoSana is projected to achieve a revenue of RMB 527 million and a net profit of RMB 48.24 million [1]. - The estimated revenue for 2025 is RMB 450 million, with an anticipated net profit of RMB 39.31 million (2025 data is unaudited) [1].

Core Viewpoint - The company aims to enhance its strategic layout and achieve high-quality development through the acquisition of 100% equity in Noah San诺 (Taicang) Biotechnology Co., Ltd. [1] Group 1: Acquisition Details - On February 4, 2026, the company signed a share acquisition intention agreement with Noah San诺 Europe [1] - The company plans to acquire 80% of the target company's equity in the first transaction, with the remaining equity to be acquired after the performance commitment period [1] - The transaction price will be determined based on due diligence, auditing, and evaluation results, and will be negotiated between both parties [1]

证券代码：603020 证券简称：爱普股份 公告编号：2026-002 爱普香料集团股份有限公司 关于签订《股权收购意向协议》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 风险提示： 1、本次签订的《股权收购意向协议》是双方【爱普香料集团股份有限公司（以 下简称"爱普股份"、"公司"、"买方"）、NovoSana (Europe) B.V.（以下 简称"挪亚圣诺欧洲"、"卖方"）】建立合作关系达成的初步意向，对双方正 式签署股权转让协议无强制约束力，双方仍存在终止本次交易的可能。公司将于 本协议签署后开展进一步尽职调查工作，双方将履行各自内部审批程序，涉及本 次收购的具体事宜包括交易金额、交易方案等，将由双方根据尽职调查、审计及 评估结果等进一步协商谈判，另行签署正式的股权转让协议。只有待签署股权转 让协议的条件满足的情况下，双方才会签署正式的股权转让协议，因此，本次收 购事项尚存在不确定性。 2、在任何情况下，如双方未能在2026年4月30日前签署股权转让协议，为促成 本次交易，双方应友好协商，并延长至双方协商一致 ...

Core Viewpoint - The announcement details the completion of a share transfer involving the controlling shareholder of Aipu Flavor Group Co., Ltd., which does not affect the company's governance structure or control [2][3][7]. Group 1: Share Transfer Details - The controlling shareholder, Mr. Wei Zhonghao, signed a share transfer agreement on October 10, 2025, to transfer 29,000,000 shares, representing 7.57% of the total share capital of 383,237,774 shares, to Hangzhou Mingshe for a total price of RMB 261,000,000 [2][4]. - The transfer has received compliance confirmation from the Shanghai Stock Exchange and the share transfer registration was completed on January 8, 2026 [2][6]. - After the transfer, Hangzhou Mingshe holds 29,000,000 shares, which is 7.57% of the total share capital, and together with its concerted party, Shanghai Xinyu Investment Management Co., Ltd., they hold a total of 10.11% [2][6]. Group 2: Compliance and Lock-up Agreement - Hangzhou Mingshe has committed to a voluntary lock-up of the transferred shares for 12 months starting from the date of transfer [3][6]. - The transfer complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China, and does not trigger a mandatory tender offer [3][7]. - The transfer will not lead to any changes in the controlling shareholder or actual controller of the company, nor will it significantly impact the company's governance or ongoing operations [3][7].

Core Viewpoint - The announcement reveals that the controlling shareholder of Aipu Co., Ltd., Mr. Wei Zhonghao, plans to transfer 29 million shares, representing 7.57% of the company's total equity, to Hangzhou Mingshe Enterprise Management Co., Ltd. for a total price of 261 million RMB [1]. Group 1 - The share transfer agreement was signed on October 10, 2025, and the total transfer price is set at 261 million RMB [1]. - The transfer has received compliance confirmation from the Shanghai Stock Exchange and a securities transfer registration confirmation from China Securities Depository and Clearing Corporation Limited on January 9, 2026 [1]. - The shares being transferred are unrestricted circulating shares [1].

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 爱普香料集团股份有限公司（以下简称：公司）控股股东魏中浩先生（以 下简称：转让方或控股股东）与杭州明策企业管理有限公司（以下简称：受让方 或杭州明策）于 2025 年 10 月 10 日签署《股份转让协议》，公司控股股东魏中浩 先生拟通过协议转让方式向杭州明策转让其持有的 29,000,000 股公司无限售条 件流通股（占公司总股本 383,237,774 股的 7.57%，以下简称：标的股份），转 让总价款为人民币 261,000,000 元（以下简称：本次转让）。 ● 公司于近日收到公司控股股东魏中浩先生的通知，本次转让已取得上海 证券交易所的合规性确认，并于2026年1月9日取得中国证券登记结算有限责任公 司出具的《证券过户登记确认书》。过户日期为2026年1月8日，过户股份数为 29,000,000股（占公司总股本383,237,774股的7.57%），股份性质为无限售流通 股。 ● 本次转让完成后，杭州明策持有公司股份29,000,000股 ...

资金来源方面，原公告仅标注为自有资金，更正后补充披露涉及金融机构借款，借款期限1年，到期将 根据自有资金情况安排偿还。同时，公告新增了双方一致行动人信息，转让方一致行动人为上海轶乐实 业有限公司，受让方一致行动人为上海馨宇投资管理有限公司，因双方实际控制人存在合作关系而被认 定为一致行动人。 南方财经12月22日电，爱普股份(603020.SH)12月20日发布公告，对控股股东魏中浩先生拟协议转让公 司部分股份的相关事项进行更正及补充。据悉，魏中浩与杭州明策企业管理有限公司于10月10日签署 《股份转让协议》，拟转让2900万股无限售条件流通股（占公司总股本的7.57%），转让总价款为2.61 亿元。 本次公告的核心更正在于持股情况的统计口径，由此前单独列示股东持股调整为合并计算一致行动人持 股：转让前，魏中浩及一致行动人持股13,033.4266万股（占比34.01%），转让后持股降至10,133.4266 万股（占比26.44%）；杭州明策及一致行动人原持股975万股（占比2.54%），受让后持股增至3,875万 股（占比10.11%）。 ...